T1	B-Protein	B-Protein	0	14	Thrombopoietin	Thrombopoietin	B-NP	NN	B-protein	2	SUB	B-protein
O	O	O	15	23	supports	support	B-VP	VBZ	O	0	ROOT	O
O	O	O	24	26	in	in	B-NP	FW	O	4	AMOD	O
O	O	O	27	32	vitro	vitro	I-NP	FW	O	6	NMOD	O
O	O	O	33	42	erythroid	erythroid	I-NP	JJ	O	6	NMOD	O
O	O	O	43	58	differentiation	differentiation	I-NP	NN	O	2	OBJ	O
O	O	O	59	62	via	via	B-PP	IN	O	2	VMOD	O
O	O	O	63	66	its	its	B-NP	PRP$	O	11	NMOD	O
O	O	O	67	75	specific	specific	I-NP	JJ	O	11	NMOD	O
O	O	O	76	84	receptor	receptor	I-NP	NN	O	11	NMOD	O
T2	B-Protein	B-Protein	85	86	c	c	I-NP	NN	O	13	NMOD	O
T2	I-Protein	I-Protein	86	87	-	-	B-NP	HYPH	O	13	NMOD	O
T2	I-Protein	I-Protein	87	90	Mpl	Mpl	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	O	91	93	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	94	95	a	a	B-NP	DT	O	19	NMOD	O
O	O	O	96	101	human	human	I-NP	JJ	B-cell_line	19	NMOD	B-cell_line
O	O	O	102	110	leukemia	leukemia	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	111	115	cell	cell	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	116	120	line	line	I-NP	NN	I-cell_line	14	PMOD	I-cell_line
O	O	O	120	121	.	.	O	.	O	2	P	O

T3	B-Protein	B-Protein	123	137	Thrombopoietin	Thrombopoietin	B-NP	NN	B-protein	5	SUB	B-protein
O	O	O	138	139	(	(	O	(	O	4	DEP	O
T4	B-Protein	B-Protein	139	142	TPO	TPO	B-NP	NN	B-protein	4	DEP	B-protein
O	O	O	142	143	)	)	O	)	O	1	NMOD	O
O	O	O	144	148	acts	act	B-VP	VBZ	O	0	ROOT	O
O	O	O	149	151	on	on	B-PP	IN	O	5	VMOD	O
O	O	O	152	168	megakaryopoiesis	megakaryopoiesis	B-NP	NN	O	9	NMOD	O
O	O	O	169	172	and	and	I-NP	CC	O	9	NMOD	O
O	O	O	173	187	erythropoiesis	erythropoiesis	I-NP	NN	O	6	PMOD	O
O	O	O	188	190	in	in	B-ADVP	FW	O	5	VMOD	O
O	O	O	191	196	vitro	vitro	I-ADVP	FW	O	10	AMOD	O
O	O	O	197	200	and	and	O	CC	O	10	AMOD	O
O	O	O	201	203	in	in	B-ADVP	FW	O	10	AMOD	O
O	O	O	204	208	vivo	vivo	I-ADVP	FW	O	13	AMOD	O
O	O	O	208	209	.	.	O	.	O	5	P	O

O	O	O	210	212	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	213	221	isolated	isolate	B-VP	VBD	O	0	ROOT	O
O	O	O	222	223	a	a	B-NP	DT	O	5	NMOD	O
O	O	O	224	229	novel	novel	I-NP	JJ	O	5	NMOD	O
O	O	O	230	237	subline	subline	I-NP	NN	O	11	NMOD	O
O	O	O	237	238	,	,	O	,	O	8	P	O
O	O	O	239	241	UT	UT	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	241	242	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
O	O	O	242	243	7	7	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	243	244	/	/	I-NP	SYM	O	11	P	O
O	O	O	244	247	GMT	GMT	I-NP	NN	O	2	OBJ	O
O	O	O	247	248	,	,	O	,	O	2	P	O
O	O	O	249	253	from	from	B-PP	IN	O	2	VMOD	O
O	O	O	254	257	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	258	263	human	human	I-NP	JJ	B-cell_line	18	NMOD	B-cell_line
O	O	O	264	272	leukemia	leukemia	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	O	273	277	cell	cell	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	O	278	282	line	line	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	283	285	UT	UT	I-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	O	285	286	-	-	B-NP	HYPH	I-cell_line	23	NMOD	I-cell_line
O	O	O	286	287	7	7	I-NP	CD	I-cell_line	23	NMOD	I-cell_line
O	O	O	287	288	/	/	I-NP	SYM	O	23	P	O
O	O	O	288	290	GM	GM	I-NP	NN	O	13	PMOD	O
O	O	O	291	292	(	(	O	(	O	42	DEP	O
O	O	O	292	293	N	N	B-NP	NN	O	27	NMOD	O
O	O	O	293	294	.	.	I-NP	.	O	25	P	O
O	O	O	295	302	Komatsu	Komatsu	I-NP	NNP	O	41	NMOD	O
O	O	O	302	303	,	,	O	,	O	41	P	O
O	O	O	304	306	et	et	B-NP	FW	O	31	NMOD	O
O	O	O	307	309	al	al	I-NP	FW	O	31	NMOD	O
O	O	O	309	310	.	.	I-NP	FW	O	41	NMOD	O
O	O	O	310	311	,	,	O	,	O	41	P	O
O	O	O	312	317	Blood	Blood	B-NP	NNP	O	41	NMOD	O
O	O	O	317	318	,	,	O	,	O	41	P	O
O	O	O	319	321	89	89	B-NP	CD	O	39	NMOD	O
O	O	O	321	322	:	:	O	:	O	39	P	O
O	O	O	323	327	4021	4021	B-NP	CD	O	39	NMOD	O
O	O	O	327	328	-	-	I-NP	HYPH	O	39	P	O
O	O	O	328	332	4033	4033	I-NP	CD	O	41	NMOD	O
O	O	O	332	333	,	,	I-NP	,	O	41	P	O
O	O	O	334	338	1997	1997	I-NP	CD	O	42	DEP	O
O	O	O	338	339	)	)	O	)	O	23	NMOD	O
O	O	O	339	340	.	.	O	.	O	2	P	O

O	O	O	341	342	A	A	B-NP	DT	O	3	NMOD	O
O	O	O	343	348	small	small	I-NP	JJ	O	3	NMOD	O
O	O	O	349	359	population	population	I-NP	NN	O	0	ROOT	O
O	O	O	360	362	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	363	365	UT	UT	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	365	366	-	-	B-NP	HYPH	I-cell_line	10	NMOD	I-cell_line
O	O	O	366	367	7	7	I-NP	CD	I-cell_line	10	NMOD	I-cell_line
O	O	O	367	368	/	/	I-NP	SYM	I-cell_line	10	NMOD	I-cell_line
O	O	O	368	370	GM	GM	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	371	376	cells	cell	I-NP	NNS	I-cell_line	4	PMOD	I-cell_line
O	O	O	377	387	positively	positively	B-VP	RB	O	12	VMOD	O
O	O	O	388	395	stained	stain	I-VP	VBN	O	10	NMOD	O
O	O	O	396	399	for	for	B-PP	IN	O	12	VMOD	O
T18	B-Entity	B-Entity	400	410	hemoglobin	hemoglobin	B-NP	NN	B-protein	13	PMOD	B-protein
O	O	O	411	412	(	(	O	(	O	17	DEP	O
T19	B-Entity	B-Entity	412	414	Hb	Hb	B-NP	NN	B-protein	17	DEP	B-protein
O	O	O	414	415	)	)	O	)	O	14	NMOD	O
O	O	O	416	421	after	after	B-PP	IN	O	3	NMOD	O
O	O	O	422	423	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	424	425	7	7	I-NP	CD	O	23	NMOD	O
O	O	O	425	426	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	O	426	429	day	day	I-NP	NN	O	23	NMOD	O
O	O	O	430	438	exposure	exposure	I-NP	NN	O	18	PMOD	O
O	O	O	439	441	to	to	B-PP	TO	O	23	NMOD	O
T5	B-Protein	B-Protein	442	445	TPO	TPO	B-NP	NN	B-protein	24	PMOD	B-protein
O	O	O	445	446	.	.	O	.	O	3	P	O

O	O	O	447	451	More	More	B-NP	JJR	O	2	AMOD	O
O	O	O	452	456	than	than	I-NP	IN	O	4	NMOD	O
O	O	O	457	459	50	50	I-NP	CD	O	2	AMOD	O
O	O	O	459	460	%	%	I-NP	NN	O	16	SUB	O
O	O	O	461	463	of	of	B-PP	IN	O	4	NMOD	O
T6	B-Protein	B-Protein	464	467	TPO	TPO	B-NP	NN	B-protein	8	AMOD	B-protein
O	O	O	467	468	-	-	O	HYPH	O	6	P	O
O	O	O	468	475	treated	treat	B-NP	VBN	O	14	NMOD	O
O	O	O	476	478	UT	UT	I-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	478	479	-	-	B-NP	HYPH	I-cell_line	14	NMOD	I-cell_line
O	O	O	479	480	7	7	I-NP	CD	I-cell_line	14	NMOD	I-cell_line
O	O	O	480	481	/	/	I-NP	SYM	I-cell_line	14	NMOD	I-cell_line
O	O	O	481	484	GMT	GMT	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	485	490	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	O	491	501	positively	positively	B-VP	RB	O	16	VMOD	O
O	O	O	502	509	stained	stain	I-VP	VBN	O	0	ROOT	O
O	O	O	510	513	for	for	B-PP	IN	O	16	VMOD	O
T20	B-Entity	B-Entity	514	516	Hb	Hb	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	O	516	517	.	.	O	.	O	16	P	O

O	O	O	518	523	Using	Use	B-VP	VBG	O	10	VMOD	O
O	O	O	524	526	UT	UT	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	O	526	527	-	-	B-NP	HYPH	I-cell_line	7	NMOD	I-cell_line
O	O	O	527	528	7	7	I-NP	CD	I-cell_line	7	NMOD	I-cell_line
O	O	O	528	529	/	/	I-NP	SYM	I-cell_line	7	NMOD	I-cell_line
O	O	O	529	532	GMT	GMT	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	O	533	538	cells	cell	I-NP	NNS	I-cell_line	1	OBJ	I-cell_line
O	O	O	538	539	,	,	O	,	O	10	P	O
O	O	O	540	542	we	we	B-NP	PRP	O	10	SUB	O
O	O	O	543	551	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	552	555	how	how	B-ADVP	WRB	O	10	VMOD	O
T7	B-Protein	B-Protein	556	559	TPO	TPO	B-NP	NN	B-protein	13	SUB	B-protein
O	O	O	560	568	promotes	promote	B-VP	VBZ	O	11	SBAR	O
O	O	O	569	586	hemoglobinization	hemoglobinization	B-NP	NN	O	13	OBJ	O
O	O	O	586	587	.	.	O	.	O	10	P	O

T8	B-Protein	B-Protein	588	591	TPO	TPO	B-NP	NN	B-protein	2	SUB	B-protein
O	O	O	592	599	induced	induce	B-VP	VBD	O	0	ROOT	O
T21	B-Entity	B-Entity	600	608	tyrosine	tyrosine	B-NP	NN	O	4	NMOD	O
O	O	O	609	624	phosphorylation	phosphorylation	I-NP	NN	O	2	OBJ	O
O	O	O	625	627	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	628	631	the	the	B-NP	DT	O	8	NMOD	O
T9	B-Protein	B-Protein	632	635	TPO	TPO	I-NP	NN	B-protein	8	NMOD	B-protein
T9	I-Protein	I-Protein	636	644	receptor	receptor	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	645	648	but	but	B-NP	CC	O	16	NMOD	O
O	O	O	649	652	not	not	I-NP	RB	O	9	DEP	O
O	O	O	653	656	the	the	B-NP	DT	O	16	NMOD	O
T10	B-Protein	B-Protein	657	671	erythropoietin	erythropoietin	I-NP	NN	B-protein	16	NMOD	B-protein
T10	I-Protein	I-Protein	672	673	(	(	O	(	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	673	676	EPO	EPO	B-NP	NN	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	676	677	)	)	O	)	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	678	686	receptor	receptor	B-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	686	687	.	.	O	.	O	2	P	O

O	O	O	688	693	There	There	B-NP	EX	O	2	SUB	O
O	O	O	694	697	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	698	700	no	no	B-NP	DT	O	4	NMOD	O
O	O	O	701	712	competition	competition	I-NP	NN	O	2	PRD	O
O	O	O	713	720	between	between	B-PP	IN	O	4	NMOD	O
T11	B-Protein	B-Protein	721	724	TPO	TPO	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	725	728	and	and	I-NP	CC	O	8	NMOD	O
T12	B-Protein	B-Protein	729	732	EPO	EPO	I-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	733	736	for	for	B-PP	IN	O	4	NMOD	O
O	O	O	737	744	binding	binding	B-NP	NN	O	9	PMOD	O
O	O	O	745	747	to	to	B-PP	TO	O	10	NMOD	O
T13	B-Protein	B-Protein	748	751	EPO	EPO	B-NP	NN	B-protein	13	NMOD	B-protein
T13	I-Protein	I-Protein	752	760	receptor	receptor	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	760	761	.	.	O	.	O	2	P	O

O	O	O	762	767	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	768	776	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	O	777	784	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	785	789	that	that	B-SBAR	IN	O	3	VMOD	O
T14	B-Protein	B-Protein	790	793	TPO	TPO	B-NP	NN	B-protein	6	SUB	B-protein
O	O	O	794	797	has	have	B-VP	VBZ	O	4	SBAR	O
O	O	O	798	799	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	800	806	direct	direct	I-NP	JJ	O	9	NMOD	O
O	O	O	807	813	effect	effect	I-NP	NN	O	6	OBJ	O
O	O	O	814	816	on	on	B-PP	IN	O	6	VMOD	O
O	O	O	817	834	hemoglobinization	hemoglobinization	B-NP	NN	O	10	PMOD	O
O	O	O	835	838	via	via	B-PP	IN	O	6	VMOD	O
O	O	O	839	840	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	841	849	specific	specific	I-NP	JJ	O	15	NMOD	O
O	O	O	850	858	receptor	receptor	I-NP	NN	O	12	PMOD	O
O	O	O	859	861	on	on	B-PP	IN	O	15	NMOD	O
O	O	O	862	864	UT	UT	B-NP	NN	B-cell_line	22	NMOD	B-cell_line
O	O	O	864	865	-	-	B-NP	HYPH	I-cell_line	22	NMOD	I-cell_line
O	O	O	865	866	7	7	I-NP	CD	I-cell_line	22	NMOD	I-cell_line
O	O	O	866	867	/	/	I-NP	SYM	I-cell_line	22	NMOD	I-cell_line
O	O	O	867	870	GMT	GMT	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	O	871	876	cells	cell	I-NP	NNS	I-cell_line	16	PMOD	I-cell_line
O	O	O	876	877	.	.	O	.	O	3	P	O

O	O	O	878	889	Isoelectric	Isoelectric	B-NP	JJ	O	2	NMOD	O
O	O	O	890	898	focusing	focusing	I-NP	NN	O	3	SUB	O
O	O	O	899	911	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	912	916	that	that	B-SBAR	IN	O	3	VMOD	O
T15	B-Protein	B-Protein	917	920	TPO	TPO	B-NP	NN	B-protein	6	SUB	B-protein
O	O	O	921	928	induced	induce	B-VP	VBD	O	13	VMOD	O
O	O	O	929	934	fetal	fetal	B-NP	JJ	O	9	AMOD	O
O	O	O	935	938	and	and	I-NP	CC	O	9	AMOD	O
O	O	O	939	944	adult	adult	I-NP	JJ	O	11	NMOD	O
T22	B-Entity	B-Entity	945	947	Hb	Hb	I-NP	NN	O	11	NMOD	O
O	O	O	948	957	synthesis	synthesis	I-NP	NN	O	6	OBJ	O
O	O	O	957	958	,	,	O	,	O	13	P	O
O	O	O	959	966	whereas	whereas	O	IN	O	4	SBAR	O
T16	B-Protein	B-Protein	967	970	EPO	EPO	B-NP	NN	B-protein	15	SUB	B-protein
O	O	O	971	978	induced	induce	B-VP	VBD	O	13	VMOD	O
O	O	O	979	988	embryonic	embryonic	B-NP	JJ	O	23	NMOD	O
O	O	O	988	989	,	,	I-NP	,	O	23	P	O
O	O	O	990	995	fetal	fetal	I-NP	JJ	O	23	NMOD	O
O	O	O	995	996	,	,	O	,	O	23	P	O
O	O	O	997	1000	and	and	O	CC	O	23	NMOD	O
O	O	O	1001	1006	adult	adult	B-NP	JJ	O	23	NMOD	O
T23	B-Entity	B-Entity	1007	1009	Hb	Hb	I-NP	NN	O	23	NMOD	O
O	O	O	1010	1019	synthesis	synthesis	I-NP	NN	O	15	OBJ	O
O	O	O	1019	1020	.	.	O	.	O	3	P	O

O	O	O	1021	1025	Thus	Thus	B-ADVP	RB	O	5	VMOD	O
O	O	O	1025	1026	,	,	O	,	O	5	P	O
O	O	O	1027	1030	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	O	1031	1035	data	datum	I-NP	NNS	O	5	SUB	O
O	O	O	1036	1043	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1044	1048	that	that	B-SBAR	IN	O	5	VMOD	O
T17	B-Protein	B-Protein	1049	1052	TPO	TPO	B-NP	NN	B-protein	8	SUB	B-protein
O	O	O	1053	1056	has	have	B-VP	VBZ	O	6	SBAR	O
O	O	O	1057	1058	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	1059	1067	distinct	distinct	I-NP	JJ	O	11	NMOD	O
O	O	O	1068	1074	action	action	I-NP	NN	O	8	OBJ	O
O	O	O	1075	1077	on	on	B-PP	IN	O	8	VMOD	O
O	O	O	1078	1092	erythropoiesis	erythropoiesis	B-NP	NN	O	12	PMOD	O
O	O	O	1092	1093	.	.	O	.	O	5	P	O
